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Case Presentation
Dr Ortiz: The patient is a 62-year-old woman with a 90–pack-year smoking
history who was seen with a chief complaint of intermittent skin lesions over her
trunk and extremities for the past 3 years. The lesions had recently grown in size,
and a large painful ulceration had appeared in her left groin. An extensive evaluation
of the maculopapular skin lesions had been undertaken previously, and the working
diagnosis of her dermatologist was Grover’s disease.1 During my evaluation a
routine chest radiograph revealed an anterior mediastinal mass, which was verified
by computed tomography to be a 7.5-cm circumscribed contrast-enhancing mass.
On examination the patient appeared healthy, and her vital signs were within normal
limits. Pertinent findings included distant breath sounds and a rash over her chest
and extremities, which will be described in detail by Dr Boh. There was also an
ulcerated lesion several centimeters in size in her left vulvar area, and this lesion will
be addressed by Dr Lottinger. In anticipation of surgical removal of the patient’s
anterior mediastinal mass, pulmonary function tests were performed. Spirometry
revealed a forced vital capacity that was 79% of predicted and a forced expiratory
volume in 1 second that was 59% of predicted. Residual volume was 115%. The
patient’s electrocardiogram was abnormal, as were results of an exercise stress test.
She therefore underwent cardiolyte stress testing with sestamibi, which demonstrated no
ischemic changes; however, the mediastinal mass was evident, as will be discussed by
Dr Campeau. The patient was then referred to Dr Hartz for surgical excision of the mass.
Dr Campeau: Computed chest tomography revealed a 7.5-cm circumscribed,
contrast-enhancing mass with a central area of nonenhancement consistent with
necrosis or cystic change. These findings were more evident on the nuclear myo-
cardial stress test, which showed a large mediastinal mass with intense sestamibi
activity but no central area devoid of activity (Figure 1).
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Dr Hartz: Dr Campeau, I was surprised to see such
intense nuclear activity in an extracardiac location. Can you
describe the significance of this finding?
Dr Campeau: Extracardiac sestamibi activity is occa-
sionally evident on nuclear stress examinations. The finding
is almost always significant, and the differential diagnosis of
sestamibi activity in chest masses includes both benign and
malignant processes. In this patient with an anterior medi-
astinal mass, the most probable diagnosis is thymoma, but
despite the circumscribed appearance malignancy cannot be
ruled out. Less likely possibilities include lymphoma and
mediastinal teratoma.
Dr Ortiz: Dr Lottinger, can you describe the findings when
the patient came to you for evaluation of the painful groin
lesion?
Dr Lottinger: She had first noticed a blister in her left
groin, which resolved spontaneously, 4 months previously.
She then had a raised painful mass develop in a similar
location a few months later. On examination, there was a
4  3-cm raised, weepy mass over the left labia majora and
extending into the groin crease (Figure 2, A). There was no
associated lymphadenopathy. A punch biopsy of the lesion
9 weeks before thymectomy revealed eosinophilic pustular
dermatitis (Figure 2, B-D). Special stains for organisms,
including fungi, were negative, and there were no granulo-
mas seen. The differential diagnosis suggested by the der-
matopathologist included pemphigus vegetans, blastomyco-
sis, and halogenoderma. I offered complete excision of this
painful mass, but the patient elected to defer this approach
until after her chest surgery.
Dr Ortiz: Dr Boh, can you provide the rationale for the
initial diagnosis of Grover’s disease in this patient and also
describe the results of the skin biopsies performed by you?
Dr Boh: Biopsy specimens of the crusted vesicular le-
sions on the patient’s trunk initially demonstrated varying
degrees of acantholysis and a lymphocytic or neutrophilic
infiltrate with eosinophils. The acantholytic process and
neutrophilic infiltrate were suggestive of Grover’s disease,
transient acantholytic dermatosis, or pemphigus, but the
distribution of the lesions was atypical for Grover’s disease.
Because of the abnormal clinical and histologic patterns, our
working diagnosis was transient acantholytic disease. Var-
ious therapies were used, but new lesions continued to develop.
Seven weeks after thymectomy, new pruritic vesicular
pustules developed on the patient’s left breast (Figure 3, A)
and leg. Biopsy of the leg lesion demonstrated intraepider-
mal vesicular dermatitis with numerous eosinophils (Figure
3, b and c). Direct immunofluorescence done on the breast
lesion showed granular and intercellular deposits of immu-
noglobulin (Ig) G, to a lesser degree for IgA and comple-
ment component C3, and faintly for IgM. There were also
faint linear deposits of C3 at the dermoepidermal junction.
These findings supported a diagnosis of pemphigus, and
possibly paraneoplastic pemphigus.2 In view of the clinical
presentation, I favored pemphigus erythematosus, an auto-
immune vesicular eruption. The bullae are formed as a
result of deposition of immunoreactants, primarily IgG and
complement, in the intercellular spaces. Pemphigus erythem-
atosus has been reported in patients with thymoma, both be-
nign and malignant, with Castleman’s disease, and with ma-
lignancies.
Dr Hartz: Although the radiographic evaluation sug-
gested a benign thymic neoplasm, the paraneoplastic skin
manifestations were worrisome. The patient was counseled
about the potential malignant nature of the tumor and the
fact that her pulmonary disease precluded sacrifice of a
phrenic nerve (for complete removal) if the mass proved to
be a malignant thymoma. She accepted these considerations
and agreed to the operation. The mass was approached with
a cosmetic, partial sternal-splitting incision. The sternotomy
was J-shaped and extended into the left fourth intercostal
space. Through this incision an extensive thymectomy was
performed; this included skeletonization of the innominate
vein and removal of all thymic tissue. There was a large
encapsulated mass in the thymus, which will be described
by Dr Daroca. The patient had no postoperative problems
and was discharged home on day 3.
Dr Ortiz: Dr Hartz, can you explain the rationale for
performing a limited sternotomy in this patient? Had this
lesion been malignant in behavior, could all the tissue have
been removed through this incision?
Dr Hartz: Recently cardiothoracic surgeons have be-
come more adept at limited-access surgery, even for replac-
ing heart valves and repairing intracardiac defects in infants.
The operation performed on this patient is currently my
Figure 1. Nuclear myocardial stress test. Note mass (thymic
tumor) above left ventricular myocardium in left anterior oblique
projection. Uptake of radioactivity is also noted beneath heart in
liver.
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preferred method of approaching anterior mediastinal
masses. In this case, the patient’s impaired pulmonary func-
tion was further impetus for this approach, because the body
of the sternum was not separated from one side of the
manubrium and she had no respiratory embarrassment after
the operation. We have reported this approach in a series of
patients, and it is diagramed in Figure 4. Dr Daroca, will
you please describe the pathology of the tumor?
Dr Daroca: The resected thymic neoplasm is an encap-
sulated thymoma. The capsule is intact, and there is no
evidence of invasion of mediastinal soft tissues accompa-
nying the specimen. The tumor has prominent spindled cell
patterns. There are also focal pseudorosettes, a well-de-
scribed variant in thymoma. Small lymphocytes are dis-
persed throughout the background of the neoplasm. No
areas of necrosis or cytologic atypia were noted. The patho-
logic findings are illustrated in Figure 5).
Dr Hartz: The patient was seen in follow up 6 weeks
after surgery. At that time, the ulcerated lesion over her
groin crease had resolved considerably and the macular skin
lesions over her trunk were almost gone. The chest incision
was well healed, and there was no seroma beneath the
subcutaneous flap. The patient was contacted 2 years after
surgery, at which time she stated that the groin lesion had
completely resolved and not recurred. However, she had
intermittent mild recurrences of the trunk and extremity
lesions, which were being symptomatically controlled with
dapsone. Dr Boh, what is the rationale for treating the skin
lesions with this medication?
Dr Boh: Dapsone is often used as a steroid-sparing
agent. This medication has a significant impact on lympho-
cyte and neutrophil chemostasis and also decreases pruritus.
Because pemphigus erythematosus appears to involve acti-
vated lymphocytes and deposition of immunoreactants
Figure 2. Left groin lesion. A, Gross photograph of ulcerated lesion before thymectomy. B, Photomicrograph
demonstrating suprabasilar acantholytic dermatosis associated with epithelial hyperplasia and prominent dermal
and intravesicular eosinophilia (hematoxylin and eosin, original magnification 100). C, Intraepidermal vesicle in
stratum spinosum contains numerous eosinophils and devitalized acantholytic keratinocytes. This focus has
features of intraepidermal eosinophilic abscess (hematoxylin and eosin, original magnification 200). D, In this
400 (original magnification) view, suprabasilar acantholytic vesicle contains neutrophils, eosinophils, and
acantholytic keratinocyte.
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within the epidermis, dapsone and other immunomodula-
tory drugs appear to be effective therapy. Both pemphigus
erythematosus and paraneoplastic pemphigus have been re-
ported in the settings of thymoma and myasthenia gravis. In
paraneoplastic pemphigus, patients have painful oral lesions
in addition to acantholytic intraepidermal bullae.
Dr Hartz: Dr Daroca, can you explain the pathologic
basis of the paraneoplastic manifestations in this patient?
Dr Daroca: Paraneoplastic pemphigus is a vesiculobul-
lous cutaneous disorder that is seen in association with
internal neoplasms, especially those of lymphoid type. The
initial criteria2 outlined in 1990 for this cutaneous disorder
Figure 3. Trunk lesions. A, Gross photograph of breast lesion. B, Histologic preparation of leg lesion shows vesical
high in epidermis with few keratinocytes in roof of vesicle. Patterns in floor of vesicle are in keeping with
re-epithelialization. Erythrocytes, occasional eosinophils, and granular proteinaceous material are present in
vesicle. There is superficial perivascular dermal infiltrate of eosinophils and lymphocytes (hematoxylin and eosin,
original magnification 100). C, In this section of leg lesion, dermis contains prominent perivascular eosinophilic
infiltrate (hematoxylin and eosin, original magnification 400).
Hartz and Daroca Clinical-Pathologic Conference
The Journal of Thoracic and Cardiovascular Surgery ● Volume 125, Number 2 403
CP
C
included the following: (1) the development of mucosal
erosions and a papular skin eruption that progresses to
blistering and erosive lesions affecting the trunk, extremi-
ties, palms, and soles; (2) an occult or known neoplasm; (3)
cutaneous histologic changes of interface dermatitis, kera-
tinocytic necrosis, and intraepidermal acantholysis; (4) di-
rect immunofluorescence showing deposits of IgG and C3
in the epidermal intercellular spaces and often granular or
linear complement deposition along the epidermal basement
membrane zone; and (5) serum antibodies that bind to cell
surfaces of skin and mucosa in a pattern typical for pem-
phigus but also bind to transitional epithelium. Anhalt2
observed that not all patients fulfill each of these criteria,
that acantholysis is most readily detectable in the oral le-
sions of patients early in the course of the disease, and that
the cutaneous lesions can be highly polymorphic. He also
noted that blistering lesions may not occur in some patients
but that treatment resistant stomatitis remains a constant
feature of the disease. The cutaneous lesions are clinically
polymorphic and may resemble an array of vesiculobullous
disorders, including pemphigus vulgaris, erythema multi-
forme, pemphigus erythematosus, pemphigus vegetans,
pemphigus foliaceus, cutaneous lupus erythematosus, bul-
lous pemphigoid, cicatricial pemphigoid, and lichen planus
pemphigoides. Patients with this disorder associated with a
malignant neoplasm usually have a poor prognosis, al-
though prolonged survival has been reported.2
Dr Hartz: Dr Daroca, I was somewhat confused by the
fact that the biopsy specimens yielded different diagnoses.
Is this typical for lesions of paraneoplastic pemphigus?
Furthermore, this is the first case of paraneoplastic skin
manifestations associated with a benign chest tumor that I
Figure 4. Diagrammatic representation of surgical incision. Dot-
ted line represents skin incision. Solid line represents sternot-
omy.
Figure 5. Thymoma. A, In low-power photomicrograph, thymoma
is surrounded by thick, fibrous capsule. Neoplastic thymic epi-
thelial cells are suspended in lymphoid stroma (hematoxylin and
eosin, original magnification 100). B, In this region, pseudoro-
settes of thymic epithelial cells are prominent (hematoxylin and
eosin, original magnification 200). C, In another region, epithe-
lial component of tumor is primarily spindled (hematoxylin and
eosin, original magnification 200).
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have personally treated. Can you elaborate on other condi-
tions associated with paraneoplastic pemphigus?
Dr Daroca: As noted before, the histopathologic features
are as variable as the polymorphous clinical cutaneous
presentations, and indeed with this patient’s biopsy speci-
mens, categorization of her vesiculobullous cutaneous dis-
ease was somewhat problematic. The dermatopathologist
included pemphigus vegetans in the differential diagnosis.
Regarding your second question, neoplasms associated with
paraneoplastic pemphigus include both benign and malig-
nant neoplasms, the latter being more common, and are
predominantly of hematopoietic or reticuloendothelial ori-
gin and include non-Hodgkin’s and Hodgkin’s lymphomas,
chronic lymphocytic leukemia, lymphomatoid granuloma-
tosis, mycosis fungoides, thymoma (benign and malignant),
Castleman’s disease, and Waldenstrom’s macroglobuline-
mia. Other neoplasms associated with paraneoplastic pem-
phigus include Kaposi’s sarcoma and carcinomas of the
breast, skin, mucous membranes, lung, uterus and cervix,
ovary, stomach, liver, and gastrointestinal tract.3
Cruz and associates4 described a patient with myasthenia
gravis, a cutaneous disorder with features of pemphigus
erythematosus or lupus erythematosus, and an encapsulated
benign thymoma consisting of spindled cells. The skin
eruption was present both before and after the removal of
the thymoma. Oral and tongue ulcers were present. There
was a clinical butterfly eruption, and histologic findings of
an interface lichenoid dermatitis supported a diagnosis of
cutaneous lupus erythematosus. Results of direct and indi-
rect immunofluorescence studies were consistent with pem-
phigus erythematosus (intercellular substance antibody
[IgG] in the mid and upper epidermis) and a focal granular
(stippled) band of IgG and C3 at the dermoepidermal junc-
tion. In their review of the literature, Cruz and associates4
identified 16 cases of pemphigus associated with myasthe-
nia gravis and thymoma, 11 associated with myasthenia
gravis alone, and 8 associated with thymitis or thymoma
alone. Almost half (43%) of the patients had pemphigus
erythematosus, and another third had pemphigus vulgaris.
The effect of thymic ablation on the course of the skin
disease was variable. In a separate literature review, Younus
and Ahmed3 noted that 18 cases of pemphigus and thymic
neoplasia were reported. Pemphigus vulgaris and erythem-
atosus were equally common in the setting of thymoma,
each occurring in 44% of cases, and pemphigus foliaceus
was seen in 11% of cases. Sixty-seven percent of patients
had benign thymoma, and only 2 had malignant thymoma.
The sequential relationship between the skin manifestations
and thymoma was variable. In more than half of the cases
the thymoma preceded pemphigus (mean 89 months), in
22% the thymoma was detected after the diagnosis of pem-
phigus (mean 25 months), and in only 1 case were the
disorders diagnosed simultaneously. The association of
pemphigus, thymoma, and autoimmune disease was re-
viewed by Patten and Dijkstra.5 Myasthenia gravis is by far
the most common associated autoimmune disease. Other
autoimmune diseases include erythroid aplasia, systemic
lupus erythematosus, and bullous pemphigoid. Pemphigus
vulgaris, pemphigus erythematosus, and pemphigus folia-
ceus occur at nearly equal frequencies.
Dr Hartz: Dr Boh evaluated the patient for a connective
tissue disorder, and the workup was negative. Is there an
autoimmune background in this skin disorder?
Dr Daroca: Although the skin diseases in this setting are
described under the rubric of paraneoplastic pemphigus,
perhaps a more precise label would be cutaneous paraneo-
plastic autoimmune vesiculobullous disease. The autoanti-
bodies in the serum of patients with paraneoplastic pemphi-
gus immunoprecipitate a complex of high–molecular weight
proteins from keratinocytes with relative molecular weights
of 250, 230, 210, 190, and 170 kd. The 250-kd antigen is
now known to represent desmoplakin I, and the 210-kd
antigen represents desmoplakin II (desmosomal plaque pro-
teins). The 230-kd antigen is bullous pemphigoid antigen.2
Antibodies to a 130-kd antigen (similar to that seen in
pemphigus vulgaris) have also been detected.6 The desmo-
plakins play a pivotal role in anchoring the network of
intermediate filaments to desmosomes. The 130-kd antigen
in pemphigus vulgaris is desmoglein 3. Desmogleins are
desmosomal cadherins (calcium-dependent adhesion mole-
cules). Desmoglein 3 is found primarily in the spinous layer
of the epidermis and is the target antigen in pemphigus
vulgaris. Desmoglein 1 is expressed primarily in the upper
layer of the epidermis and is the target antigen in pemphigus
foliaceus.6
Dr Hartz: Dr Daroca, after this extensive discussion,
what is your final diagnosis of our patient’s skin condition?
Dr Daroca: The histopathologic findings of the vesicu-
lobullous cutaneous disorder in the present case share fea-
tures with pemphigus vegetans. The biopsy specimen from
the left groin best illustrates the active acantholytic process.
Dr Boh will subsequently address clinical and direct immu-
nofluorescent findings, which are not typical of pemphigus
vegetans. The skin lesion represented in the leg biopsy
specimen probably reflects an older, partially re-epithelial-
ized nonacantholytic lesion. Pemphigus vegetans has been
reported in the region of the vulva,7 and in pemphigus
vegetans peripheral eosinophilia and oral lesions are fre-
quent.8 Cases of pemphigus vegetans have been reported in
association with the drugs captopril (an antihypertensive
agent that is a competitive inhibitor of angiotensin I–con-
verting enzyme) and with enalapril (a combination angio-
tensin-converting enzyme inhibitor and hydrochlorothia-
zide).9,10 Our patient was receiving neither of these
medications. In the report by Bastiaens and colleagues,10 1
of 3 patients with pemphigus vegetans had an associated
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squamous cell carcinoma of the lung. The cutaneous lesions
of pemphigus vegetans antedated the diagnosis of lung
cancer by 3 months and were present in the left axilla and in
both the right and left groins. The authors noted that the
cutaneous lesions and circulating antibodies disappeared
after removal of the tumor.
Dr Hartz: Dr Boh, are your diagnoses (pemphigus ery-
thematosus and transient acantholytic dermatosis) consis-
tent with Dr Daroca’s impression of pemphigus vegetans?
Dr Boh: Pemphigus represents a spectrum of variants,
including the classic pemphigus vulgaris, pemphigus ery-
thematosus, and pemphigus vegetans. Clinically, pemphi-
gus erythematosus has flaccid bullae and erosions, typically
in a seborrheic distribution. Pemphigus vegetans has a
heaped up lichenified or vegetative appearance, often with-
out evidence of blisters or erosions. Although the groin
lesion was acanthotic or thickened, the other clinical lesions
were flaccid bullae and erosions without a thickened or
vegetative appearance. The clinical appearance and distri-
bution of the lesions, coupled with histologic and immuno-
histochemical studies, support the diagnosis of pemphigus
erythematosus. Immunohistochemical analysis of a pemphi-
gus vegetans lesion would show intercellular IgG but no
linear band of immunoreactants at the dermal-epidermal
junction. As you recall, there was a faint linear band of IgG
at the dermal-epidermal junction in the breast biopsy spec-
imen.
Dr Daroca: Perhaps the best label to describe this pa-
tient’s cutaneous disorder would be paraneoplastic autoim-
mune vesiculobullous disease.
Dr Hartz: In summary, our patient had a benign thy-
moma and an associated paraneoplastic vesiculobullous
skin disorder that had variable clinical presentations and
pathologic findings, depending both on the area of presen-
tation (leg, breast, groin) and the duration of the eruption. A
new variant of a partial sternotomy was used to remove the
tumor. The patient did well after the operation, and the skin
lesions were almost resolved within a few weeks. In patients
with vesiculobullous skin lesions, a high index of suspicion
is necessary to detect and treat associated neoplasms in a
timely fashion.
We acknowledge Richard J. Reed, MD (pathologist), and
Donna Turner and Linda Hill (manuscript preparation).
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